Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy

Van Staa, T. P., Laan, R. F., Barton, I. P., Cohen, S., Reid, D. M., Cooper, C.·2003·Arthritis & Rheumatism
DOI 10.1002/art.11283

Cited by (556)

Items 401–500 of 556

  1. A Preliminary Study of the Effect of Hyperadrenocorticism on Calcium and Phosphate Concentrations, Parathyroid Hormone and Markers of Bone Turnover in Dogs
    Carmel T. Mooney, Robert E. Shiel, Mary Sekiya, Mark Dunning, Eilidh Gunn · 2020 · Frontiers in Veterinary Science
  2. Therapies for Preventing Bone Loss with Glucocorticoid Treatment
    Arnav Agarwal, Jonathan Derrick Adachi · 2021 · Current Osteoporosis Reports
  3. Glucocorticoid-Induced Osteoporosis
    Michael J. Maricic · 2009 · Humana Press eBooks
  4. Efficacy and safety of minodronic acid hydrate in patients with steroid‐induced osteoporosis
    Noboru Kitamura, Hidetaka Shiraiwa, Hirotake Inomata, Takamasa Nozaki, Natsumi Ikumi, Kaita Sugiyama, Yousuke Nagasawa, Hiromi Karasawa, Mitsuhiro Iwata, Yoshihiro Matsukawa et al. · 2016 · International Journal of Rheumatic Diseases
  5. Bone Mineral Density Assessment in Premenopausal Women
    Aliya Aziz Khan, Zeba A. Syed · 2006 · Women s Health
  6. New observations on bone fragility with glucocorticoid treatment. Results from an in vivo animal model.
    Nancy E. Lane · 2005 · PubMed
  7. Understanding Bone Strength from Finite Element Models: Concepts for Non-engineers
    Christopher J. Hernandez, Erin N. Cresswell · 2016 · Clinical Reviews in Bone and Mineral Metabolism
  8. Update on the Treatment of Glucocorticoid-Induced Osteoporosis
    Ai Lee Lim, Swan Sim Yeap · 2022 · Journal of Clinical Rheumatology and Immunology
  9. Glucocorticoid-Induced Bone Loss Is Associated with Abnormal Intravertebral Areal Bone Mineral Density Distribution
    Louise I. Manning, Andrew M. Briggs, Sharon Van Doornum, Ashwini Kale, Susan Kantor, John Dennis Wark · 2013 · International Journal of Endocrinology
  10. Does the oral steroid treatment of patients with nasal polyposis cause osteopenia or osteoporosis?
    P. Sahlstrand-Johnson, Mats Holmström, Anders Ehnhage · 2019 · Clinical Otolaryngology
  11. Low pre-pregnant body mass index is a risk factor for the decrease of postpartum bone mineral density in systemic lupus erythematosus patients received glucocorticoid therapy
    Takaaki Ishida, Yuri Hiramatsu, Eri Nakamura, Kentaro Isoda, Yumiko Wada, Takuya Kotani, Tohru Takeuchi · 2022 · Lupus
  12. Comparative effectiveness of bisphosphonate treatments for the prevention of re-fracture in glucocorticoid-induced osteoporosis: protocol for a systematic review and meta-analysis
    Hongmin Chu, Bo-Hyoung Jang, GaYoon Kim, Seowoo Bae, Hyeju Lee, Seonghee Nam, Jeonghoon Ahn · 2022 · BMJ Open
  13. Threshold based on bone mineral density for therapeutic decision-making in postmenopausal women and men over 50 years old under glucocorticoid therapy
    María Lorena Brance, María Silvia Larroudé, Luis Fernando Somma, Evangelina Giacoia, María Diehl, Ana Maria Galich, Luis Agustín Ramírez Stieben, María Cielo Maher, María De La Vega, Ariana Ringer et al. · 2022 · Reumatología Clínica
  14. Potential Benefits of Annatto Tocotrienol in Glucocorticoid Induced Osteoporosis: An Animal Study
    Ima Nirwana Soelaiman, Elvy Suhana Mohd Ramli, Farihah Hj Suhaimi, Fairus Ahmad · 2017 · Journal of Osteoporosis and Physical Activity
  15. Osteoporosis
    Roland D Chapurlat, Harry K. Genant · 2015 · Elsevier eBooks
  16. Vertebral Compression Fractures in Elderly Osteoporosis Patients Receiving Glucocorticoid Intra‐articular Injections
    Marc Alan Huntoon · 2006 · Pain Practice
  17. Osteoporose bei pneumologischen Erkrankungen
    Christian Muschitz, Ralf Harun Zwick, Judith Haschka, Hans Peter Dimai, Martina Rauner, Karin Amrein, Robert Wakolbinger, Péter Jaksch, Ernst Eber, Peter Pietschmann · 2021 · Wiener klinische Wochenschrift
  18. Bone turnover decreases and bone structure improves during treatment with weekly high-dose methylprednisolone for 12 weeks in Graves’ orbitopathy
    Torben Harsløf, Rawan Hikmet, Eva Ebbehøj, Bente Lomholt Langdahl · 2023 · Endocrine
  19. Prevalence of osteoporosis and the use of bone protective therapies in dermatology clinic patients on long‐term glucocorticoids
    Sally K. Abell, Howard Zeimer, Alvin H Chong, Richard J. MacIsaac · 2015 · Australasian Journal of Dermatology
  20. Osteoporosis in Patients with Peripheral Neuropathies
    Mendel Kupfer, Christina V. Oleson · 2017 · Springer eBooks
  21. Treatment of Glucocorticoid-Induced Osteoporosis and Risk Factors for New Vertebral Fractures in Female Patients with Autoimmune Diseases
    Koichiro Shinoda, Hirofumi Taki · 2021 · Journal of Osteoporosis
  22. Paradoxically protective effect of glucocorticoids on bone mass and fragility fracture in a large cohort: a cross-sectional study
    Marwan A S Bukhari, Nicola J. Goodson, Maarten Boers · 2021 · Rheumatology Advances in Practice
  23. Trabecular Bone Score in der Rheumatologie
    Zhivana Boyadzhieva, Andriko Palmowski, Frank Buttgereit, Paula Hoff · 2023 · Zeitschrift für Rheumatologie
  24. Ukrainian guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis
    Nataliia V. Grygorieva, Volodymyr Kovalenko, М.О. Коrzh, Mykola D. Tronko, I.Yu. Golovach, Ninel V. Dedukh, Д. Г. Рекалов, С.С. Страфун, Svitlana Smiyan, Olga A. Golubovska et al. · 2024 · PAIN JOINTS SPINE
  25. Glucocorticoid-induced osteoporosis in systemic lupus erythematosus
    Kee Fong Phang, Jiacai Cho, Weixian Lee, Anselm Mak · 2018 · Rheumatology Practice and Research
  26. Bone Density and Imaging of Osteoporosis
    Roland D Chapurlat, Pierre Dominique Delmas, Harry K. Genant · 2010 · Elsevier eBooks
  27. AVASCULAR NECROSIS DUE TO CORTICOSTEROID THERAPY IN COVID-19 AS A SYNDEMIC
    Serkan Ergözen, Egemen Kaya · 2021 · Central Asian Journal of Medical Hypotheses and Ethics
  28. Ostéoporose cortisonique
    Christian Marcelli · 2011 · EMC - Appareil locomoteur
  29. Ostéoporose secondaire à la corticothérapie systémique
    Béatrice Bouvard, Érick Legrand, Maurice Audran, Daniel Chappard · 2011 · Revue du Rhumatisme Monographies
  30. Managing Osteoporosis in Primary Care: Highlights from Osteoporosis Canada Guidelines
    2011 · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
  31. Risk Factors, Prevention, and Treatment of Corticosteroid-induced Osteoporosis in Adults
    Kathryn M. Ruf, Nicole K. Johnson, Timothy M. Clifford, Kelly M. Smith · 2008 · Orthopedics
  32. Influence of prednisolone on craniofacial and long bones in growing rats: A cephalometric and peripheral quantitative computed tomographic analysis
    Yūkō Fujita, Takahiro Nishioka, Takashi KINJO, Kenshi Maki · 2007 · Pediatric Dental Journal
  33. Osteoporosis: The Need for Prevention and Treatment
    Karan Baucom, Lara Pizzorno, Joseph E. Pizzorno · 2014 · Journal of Restorative Medicine
  34. Interventions to prevent steroid-induced osteoporosis and osteoporotic fractures in Duchenne muscular dystrophy
    Jennifer M Bell, Bronagh Blackwood, Michael David Shields, Janet Watters, Alistair Hamilton, Timothy R. O. Beringer, Mark Elliott, Rosaline C. M. Quinlivan, Sandya Tirupathi · 2014 · Cochrane Database of Systematic Reviews
  35. Chronic obstructive disease and comorbidities (literature review)
    Ecaterina Stavila, Victor Botnaru, Doina Rusu, Alexandru Corlăteanu · 2021 · Bulletin of the Academy of Sciences of Moldova Medical Sciences
  36. Ukrainian guideline for the prevention and treatment of glucocorticoid-induced osteoporosis
    Nataliia V. Grygorieva, Volodymyr Kovalenko, Mykola Korzh, Mykola D. Tronko, I.Yu. Golovach, Ninel V. Dedukh, Д. Г. Рекалов, С.С. Страфун, Svitlana Smiyan, Olga A. Golubovska et al. · 2025 · Archives of Osteoporosis
  37. Genistein Aglycone Demonstrates a Protective and Reversible Effect on the Development of Steroid-Induced Secondary Osteoporosis and Increases Bone Breaking Strength in Vivo
    Lakshmi Pillai, Alessandra Bitto, Bruce P. Burnett, Francesca Polito, Robert M. Levy, Vincenzo Di Stefano, Mary Ann Armbruster, Herbert Ryan Marini, Natasha Irrera, Domenica Altavilla et al. · 2010 · Journal of Clinical Densitometry
  38. A hospital-based study of prophylactic therapy in glucocorticoid-induced osteoporosis
    Sarath Lekamwasam · 2010 · Ceylon Medical Journal
  39. Health Maintenance in Patients with Ulcerative Colitis
    Jason W. Harper · 2020 · Gastroenterology Clinics of North America
  40. Treatment and Prevention of Glucocorticoid-Induced Osteoporosis
    Robert G. Micheletti, Dedee Frances Murrell, Victoria P. Werth · 2015 · Springer eBooks
  41. Corticosteroid Is Associated with Both Hip Fracture and Fracture-Unrelated Arthropathy
    Feng‐Chen Kao, Yao‐Chun Hsu, Chien‐Fu Lin, Ying-Ying Lo, Yuan-Kun Tu · 2017 · PLoS ONE
  42. Evaluation of Steroid-Induced Osteoporosis Prevention Using Tracing Reports in Collaboration between Hospitals and Community Pharmacists
    Nonoko Ishihara, Shuji Yamashita, Shizuno Seiki, Keito Tsutsui, Hiroko Kato‐Hayashi, Shuji Sakurai, Kyoko Niwa, Takuyoshi Kawai, Junko Kai, Akio Suzuki et al. · 2024 · Pharmacy
  43. Fucoxanthin restores mitochondrial bioenergetics and attenuates dexamethasone-induced osteoblast Dysfunction: Implications for glucocorticoid-associated bone disorders
    Ekramy Mahmoud Elmorsy, Ayat Badr Al-Ghafari, Huda Abdulaziz Al Doghaither, Ruba O. Almaghrabi, Samah Fathy Ibrahim, Gamal Othman, Ateya Megahed Ibrahim, Ahmed Abdeen · 2025 · Food and Chemical Toxicology
  44. glucocorticoid osteoporosis; osteoporotic fracture; bisphosphonates; FRAX algorithm
    Natalia V. Toroptsova, Irina Aleksandrovna Baranova · 2013 · Modern Rheumatology Journal
  45. Glucocorticoids and osteoporosis: predicting fracture risk
    Stanley B. Cohen · 2010 · Nature Reviews Rheumatology
  46. Prevention and treatment of glucocorticoid-induced osteoporosis in International and Italian scenarios
    Ombretta Di Munno, Andrea Delle Sedie · 2011 · Reumatismo
  47. Osteoporosis inducida por glucocorticoides: ¿qué hay de nuevo?
    María Pilar Aguado Acín · 2007 · Reumatología Clínica
  48. Effekte der Glukokortikoide auf den Knochen
    A. Lang, Paul T. Hoff, F. Buttgereit, Jonna Amann · 2014 · Osteologie/Osteology
  49. A Case of Glucocorticoid-Induced Multifocal Osteonecrosis
    2015 · Journal of Novel Physiotherapies
  50. Glucocorticoid-induced osteoporosis
    Arthur N. Lau, Philip N. Sambrook, Jonathan Derrick Adachi · 2015 · Elsevier eBooks
  51. Osteoporose induzida por glicocorticoides
    Alex Rocha Bernardes da Silva, Vera Lúcia Szejnfeld · 2019 · Revista Paulista de Reumatologia
  52. Polymyalgia Rheumatica
    Anne O’Brien · 2020 · Perspectives in nursing management and care for older adults
  53. Threshold based on bone mineral density for therapeutic decision-making in postmenopausal women and men over 50 years old under glucocorticoid therapy
    María Lorena Brance, María Silvia Larroudé, Luis Fernando Somma, Evangelina Giacoia, María Diehl, Ana Maria Galich, Luis Agustín Ramírez Stieben, María Cielo Maher, María De La Vega, Ariana Ringer et al. · 2023 · Reumatología Clínica (English Edition)
  54. Low-dose glucocorticoid increase the risk of fracture in postmenopausal women with low bone mass: a retrospective cohort study
    So Young Park, Seong Hee Ahn, Gi Hwan Bae, Sunmee Jang, Mi Kyung Kwak, Ha Young Kim, Se Hwa Kim · 2024 · Osteoporosis International
  55. Glucocorticoid-induced osteoporosis: when and who should we treat?
    Gauthier Morel, Emmanuel Biver, Séverine Borg, Florence Chopin, Emmanuel Hoppé, Gérald Rajzbaum · 2011 · Joint Bone Spine
  56. FACULTE MIXTE DE MEDECINE ET DE PHARMACIE DE ROUEN
    Hélène Eltchaninoff, Dominique Lacroix, Docteur A. Savoure · 2013
  57. Initiation of anti-osteoporotic drugs in high-risk female patients starting glucocorticoid treatment: a population study in Norway
    Ellen Margrete Apalset, Astrid Lunde, Mari Hoff, Véra Ehrenstein, Grethe Seppola Tell · 2020 · Archives of Osteoporosis
  58. Systemic glucocorticoids in rheumatology
    Kenneth G. Saag · 2011 · Elsevier eBooks
  59. Prevention of Glucocorticoid‐Induced Fractures: Which Patients Should We Treat? Comment on the Article by Grossman et al
    Lauren Dudley, Lin Brown · 2013 · Arthritis Care & Research
  60. Imagerie de la pathologie iatrogène médicamenteuse
    J.M. Tubiana, M Biour, Françoise Bavoux, G. Kalifa, Élisabeth Dion · 2005 · Journal de Radiologie
  61. Glucocorticoids on bone remodeling in systemic lupus erythematosus mice
    Sheng Hao, Yuyun Zhang, Xiaowei Tong, Fangkai Ding, Runjie Wang, Jing Zhang, Dan Feng, Xiaoling Niu, Wenyan Huang · 2025 · Pediatric Research
  62. EndoCompass Project: Research Roadmap for Calcium and Bone Endocrinology
    Katharina Jähn, Karin Zibar Tomšić, Athanasios D. Anastasilakis, Jean‐Philippe Bertocchio, Maria Luisa Brandi, Martin Faßnacht, Moira Cheung, Evelien F. Gevers, Neil J. L. Gittoes, Outi Mäkitie et al. · 2025 · Hormone Research in Paediatrics
  63. Hormone Actions in the Regulation of Calcium and Phosphorus Metabolism
    David A. Ontjes · 2011 · CRC Press eBooks
  64. Interventions and Therapy in Rheumatology
    Mario Muto, Francesco Giurazza, Giulia Frauenfelder, Stefano Marcia, Salvatore Antonio Masala, Gianluigi Guarnieri · 2017 · Radiologic Clinics of North America
  65. Glucocorticoid-Induced Osteoporosis: Are We Practicing Prevention?
    Eileen C. Rife, Jennifer Elise Abdalla, Jose Leon de la Rocha, Nkechinyere Emejuaiwe · 2023 · SN Comprehensive Clinical Medicine
  66. Clinical Perspective: What Do Addison and Cushing Tell Us About Glucocorticoid Action?
    Charles Andrew Harris · 2015 · Advances in experimental medicine and biology
  67. Adverse Effects of Drugs on Bone and Calcium Metabolism/Physiology
    Peter Vestergaard · 2007 · Clinical Reviews in Bone and Mineral Metabolism
  68. How may osteoporosis be prevented in individuals with diabetes?
    Peter Vestergaard · 2011 · Diabetes Management
  69. CONDITION OF THE MUSCULOSKELETAL SYSTEM IN PATIENTSWITH ACROMEGALY.
    A S Fedotova, Н Н Молитвословова, Л. И. Алексеева, Liudmila Y. Rozhinskaya, A. S. Fedotova, Н Н Молитвословова, L I Alexeeva, Liudmila Y. Rozhinskaya · 2010 · Osteoporosis and Bone Diseases
  70. Preliminary investigation of urine N‐telopeptide concentration as a biomarker of bone resorption in dogs receiving glucocorticoids
    Jessica Adamany, Gemma F. Cross, David S. Gardner, Mark Dunning · 2017 · Journal of Small Animal Practice
  71. Glucocorticoid-Induced Osteoporosis: Update on Management
    Aprajita Jagpal, Kenneth G. Saag · 2018 · Current Treatment Options in Rheumatology
  72. Strokovna stališča Združenja endokrinologov Slovenije o obravnavi glukokortikoidne osteoporoze
    Tomaž Kocjan, Mojca Jensterle, Janez Preželj · 2018 · Slovenian Medical Journal
  73. Masa ósea y fracturas en enfermedades reumatológicas autoinmunes
    María Lorena Brance, María Silvia Larroudé · 2017 · Revista Argentina de Reumatología
  74. AORA（Akita Orthopedic Group on Rheumatoid Arthritis） registry 2017におけるステロイド性骨粗鬆症の治療現状
    河野 哲也, 柏倉 剛, 相澤 俊朗, 宮腰 尚久, 島田 洋一 · 2019 · 東日本整形災害外科学会雑誌 = Journal of the Eastern Japan Association of Orthopaedics and Traumatology
  75. Basic and clinical aspects of glucocorticoid action in bone
    Hong Zhou, Mark Stuart Cooper, Markus J. Seibel · 2019 · Elsevier eBooks
  76. Steroid-Induced Osteoporosis; At a Glance
    Berrin Durmaz · 2019 · American Journal of Biomedical Science & Research
  77. Glucocorticoid-Induced Osteoporosis
    Gherardo Mazziotti, ERNESTO M. CANALIS, John Paul Bilezikian · 2022
  78. Osteoporosis: Epidemiology and Assessment
    Mary Beth Humphrey, Bita Zahedi, Amy H. Warriner, Sarah Morgan, Benjamin Z. Leder, Ken G. Saag, Elaine Wei-Yin Yu · 2023 · Springer eBooks
  79. Osteoporosis inducida por glucocorticoides
    Alexandre Mercier-Guery · 2024 · EMC - Aparato Locomotor
  80. Artrite reumatoide: por que tratar apenas a artrite, sabendo que comorbidades são comuns e determinam morbidade e mortalidade?
    Ivânio Alves Pereira · 2012 · Revista Brasileira de Reumatologia
  81. Treatment and Outcome of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
    Peter A. Lee, John S. Fuqua, Todd D. Nebesio · 2010 · International Journal of Pediatric Endocrinology
  82. Prévention et traitement de l’ostéoporose cortico-induite
    Christian Roux · 2006 · Annales d Endocrinologie
  83. Recommendations regarding individuals in whom bone densitometry should be performed: Comment on the article by van Staa et al
    Oscar S. Gluck, Michael J. Maricic, Edward S. Leib, Edward Michael Lewiecki · 2004 · Arthritis & Rheumatism
  84. Teriparatide or Alendronate in Glucocorticoid-Induced
    Timothy Cross, Phillip A. Berry, Andrew Kenneth Burroughs · 2008
  85. Who Should Be Screened: Who Should Be Treated?
    Michael R. McClung · 2008 · Elsevier eBooks
  86. Corticosteroid-Induced Osteoporosis
    Philip N. Sambrook, Nancy E. Lane · 2006 · Elsevier eBooks
  87. Metabolic Bone Disease in Gastrointestinal Disorders
    Ann Cranney, Catherine Dube, Alaa Rostom, Peter Tugwell, George A. Wells · 2004 · Wiley eBooks
  88. Die glukokortikoidinduzierte Osteoporose - Pathogenese, Diagnostik und Therapie
    Inga Steinebach · 2008 · Journal für Kardiologie (Krause & Pachernegg GmbH)
  89. Optimising glucocorticoid therapy in rheumatic diseases : an incompatible triangle?
    Jos N. Hoes · 2011 · Utrecht University Repository (Utrecht University)
  90. Prevalência de baixa densidade mineral óssea e fatores associados em pacientes adolescentes e adultos com fibrose cística
    Roberta Vanacor · 2012 · Americanae (AECID Library)
  91. Medikamentöse Therapie der Osteoporose
    Johannes Pfeilschifter · 2004 · Arthritis und Rheuma
  92. Doença óssea em pacientes com nefrite lúpica: aspectos inflamatórios
    Aline Lázara Resende · 2014
  93. Prevention of complications in pediatric cataract surgery
    Maria Kugelberg · 2004 · Figshare
  94. Management: Established Osteoporosis in Organ Transplant Recipients
    Ian R. Reid · 2005 · Elsevier eBooks
  95. Recurrent fractures in an elderly patient with systemic lupus erythematosus
    Faith Li‐Ann Chia, Bernard Yu‐Hor Thong, Tang‐Ching LAU, Pao‐Hsii FENG · 2009 · International Journal of Rheumatic Diseases
  96. Glucocorticoid-Induced Osteoporosis
    Božidar Ćurković · 2007 · Archives of Industrial Hygiene and Toxicology
  97. Prise en charge de l'ostéoporose cortisonique en 2005
    Philippe Orcel · 2005 · Revue du Rhumatisme
  98. Does alendronate improve bone mineral density in patients with RA treated with glucocorticoids?
    Nancy E. Lane · 2006 · Nature Clinical Practice Rheumatology
  99. Actualisation des recommandations pour la prise en charge de l’ostéoporose cortisonique
    Philippe Orcel · 2014 · Revue du Rhumatisme
  100. An update on the management of comorbid conditions in lupus nephritis
    Vassiliki Tzavara, Cristina Ana Maria Pamfil, Dimitrios T. Boumpas, George K Bertsias · 2013 · Clinical Investigation